Provided herein are sphingolipid-polyalkylamine siRNA compounds pharmaceutical compositions comprising such compounds, and methods of use in therapy.Linvention concerne des composés sphingolipide-polyalkylamine-ARNsi, des compositions pharmaceutiques comprenant ces composés et des procédés dutilisation en thérapie.